erenumab-aooe
erenumab-aooe is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including AIMOVIG. Available dosage forms: injection, solution, injection.
Drug Details
- Generic Name
- erenumab-aooe
- Brand Names
- AIMOVIG
- Application Number
- BLA761077
- Sponsor
- Amgen, Inc
- NDC Codes
- 8
- Dosage Forms
- INJECTION, SOLUTION, INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ERENUMAB
Indications and Usage
1 INDICATIONS AND USAGE AIMOVIG is indicated for the preventive treatment of migraine in adults. AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )